Saturday, March 7, 2015

Deals

MicroVision Licenses Technology to Fortune Global 100 Partner

March 5, 2015 · Leave a Comment 

REDMOND, Wash., Mar 05, 2015 (BUSINESS WIRE) — MicroVision, Inc. MVIS, +1.68% a leader in innovative ultra-miniature projection display technology, today announced it has signed a multi-year license agreement with its Fortune Global 100 partner for MicroVision PicoP® display technology. The license agreement marks an important milestone in the ongoing relationship between the two companies that began in April 2013. The license agreement grants the Fortune Global 100 company a non-exclusive license to MicroVision PicoP display technology for use in display modules it manufactures and... [Read the full story]

Deal News

MicroVision Licenses Technology to Fortune Global 100 Partner

March 5, 2015 · Leave a Comment 

REDMOND, Wash., Mar 05, 2015 (BUSINESS WIRE) — MicroVision, Inc. MVIS, +1.68% a leader in innovative ultra-miniature projection display technology, today announced it has signed a multi-year license agreement with its Fortune Global 100 partner for MicroVision PicoP® display technology. The license agreement marks an important milestone in the ongoing relationship between the two companies that began in April 2013. The license agreement grants the Fortune Global 100 company a non-exclusive license to MicroVision PicoP display technology for use in display modules it manufactures and... [Read the full story]

Legal

Asetek Announces Settlement of Lawsuit with CoolIT Systems, Inc.

February 6, 2015 · Leave a Comment 

  OSLO, Norway — Regulatory News: Asetek announces that it has settled its patent infringement lawsuit against CoolIT Systems, Inc. and agreed to dismiss the case (Asetek Danmark A/S v. CoolIT Systems, Inc., Northern District of California federal district court). Although the specific terms of the settlement are confidential, the parties have agreed to the federal district court making a determination of whether and to what extent damages are to be awarded by the court to Asetek. The court’s damages determination will be disclosed later in a separate release. About Asetek Asetek is the... [Read the full story]

Bio

Mayo Clinic and Gentag ink IP collaboration

March 5, 2015 · Leave a Comment 

  Mayo Clinic has inked a deal with biosensor developer Gentag that will focus on the needs of patients with diabetes and obesity, according to a statement from the provider. It marks Gentag’s first collaboration with a provider. The terms of the agreement involve Mayo and Gentag working with third parties under license to develop next generation wearable skin patch technologies from Gentag for diabetes and obesity management. The patent agreement with Mayo will license Mayo and Gentag joint IP and know-how will be licensed to third parties that will actually deploy the technology. Gentag’s... [Read the full story]

University Tech Transfer

Pitt, UPMC reach commercialization agreement

February 22, 2015 · Leave a Comment 

  PITTSBURGH, Feb. 20, 2015 – The University of Pittsburgh and UPMC have entered into a new agreement designed to accelerate the commercialization of intellectual property arising from the research activity of University faculty. The partnership is intended to speed the commercialization of new medical technologies and services, offering the dual benefit of bringing medical advances to the public more rapidly and supporting new business startups, with the accompanying economic benefits for the region. This agreement builds on Pitt’s core mission of impacting society through knowledge... [Read the full story]

People

idealAsset signs Strategic Partner, Innovestion, LLC.

February 28, 2015 · Leave a Comment 

  AUSTIN, Texas, Feb. 26, 2015 /PRNewswire-iReach/ – idealAsset, a division of Fluid Innovation Group, Inc., announced new client Innovestion, LLC.  Innovestion acquires, manages and monetizes IP portfolios for Fortune 500, small and mid-cap companies, as well as individual inventors, generating substantial revenues from market relevant patents for the key stakeholders. “The IP Marketplace is going through a transformation and idealAsset is leading with its ability to rapidly match IP to opportunities.  We selected their platform to help scale our monetization efforts and expand... [Read the full story]

Deals

MicroVision Licenses Technology to Fortune Global 100 Partner

REDMOND, Wash., Mar 05, 2015 (BUSINESS WIRE) — MicroVision, Inc. MVIS, +1.68% a leader in innovative ultra-miniature projection display technology, today announced it has signed a multi-year license agreement with its Fortune Global 100 partner for MicroVision PicoP® display technology. The license agreement marks an important milestone... Read more of this article


Mayo Clinic and Gentag ink IP collaboration

  Mayo Clinic has inked a deal with biosensor developer Gentag that will focus on the needs of patients with diabetes and obesity, according to a statement from the provider. It marks Gentag’s first collaboration with a provider. The terms of the agreement involve Mayo and Gentag working with third parties under license to develop next generation... Read more of this article


AbbVie to Buy Pharmacyclics in $21 Billion Deal

  AbbVie Inc. said late Wednesday it will buy cancer biotech Pharmacyclics Inc. in a $21 billion deal that returns the North Chicago, Ill., drug company to deal-making after backing away from a big tax-lowering takeover last year. The deal, a mix of cash and stock for $261.25 a share, would give AbbVie a presence in the multibillion-dollar blood-cancer... Read more of this article


OLED technology license agreement with Universal Display

  Universal Display Corporation and OLEDWorks LLC have announced the signing of a new OLED Technology License Agreement. Under the agreement, Universal Display has granted OLEDWorks non-exclusive license rights, under various patents owned or controlled by Universal Display, to manufacture and sell phosphorescent OLED lighting products. In return,... Read more of this article


TG Therapeutics, Checkpoint Therapeutics Commercialization Collaboration

  TG Therapeutics (NASDAQ: TGTX) an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of Coronado Biosciences, Inc. (Nasdaq: CNDO) to develop and commercialize Checkpoint’s fully human anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. Checkpoint will develop and commercialize... Read more of this article


Brocade to Acquire Connectem

  SAN JOSE, CA and BARCELONA, SPAIN- March 1, 2015 - Brocade (NASDAQ: BRCD) today announced its intent to acquire Connectem, a privately-held company in the LTE virtual Evolved Packet Core (vEPC) market, in an all-cash transaction. The continued explosive growth of traditional mobile data combined with emerging requirements around machine-to-machine... Read more of this article


Ucore Secures Technology Rights

  HALIFAX, NOVA SCOTIA–(Marketwired – March 3, 2015) - Ucore Rare Metals Inc. (TSX VENTURE:UCU)(OTCQX:UURAF) (“Ucore” or “the Company”) is pleased to announce that it has entered into an agreement with IBC Advanced Technologies Inc. (“IBC”) to acquire the exclusive rights to IBC’s SuperLig®... Read more of this article


DuPont Protection Technologies and adidas Sign Agreement

  DuPont Protection Technologies (DuPont) and adidas Group North America (adidas) today announced the signing of a multi-year trademark license agreement for the use of the DuPont™ Kevlar® and Dare Bigger™ trademarks in football cleats. adidas recently previewed a limited edition line of cleats that incorporate DuPont™ Kevlar® fiber, and... Read more of this article


Blueprint Medicines Announces Collaboration with Alexion

  CAMBRIDGE, Mass., March 3, 2015 /PRNewswire/ — Blueprint Medicines today announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease. Blueprint Medicines will apply its kinase-focused drug discovery... Read more of this article


Amyris & Genome Compiler Partner

  EMERYVILLE and LOS ALTOS, Calif., March 3, 2015 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), an industrial bioscience company, and Genome Compiler Corp., a synthetic biology platform company, have entered into a collaboration agreement to integrate Amyris’s automated lab services with Genome Compiler’s online design tools... Read more of this article


More Posts From Deals

Legal

Asetek Announces Settlement of Lawsuit with CoolIT Systems, Inc.

  OSLO, Norway — Regulatory News: Asetek announces that it has settled its... 


Tessera Technologies Reaches Global Settlement with Amkor

  SAN JOSE, Calif.–(BUSINESS WIRE)–Tessera Technologies, Inc. (NASDAQ:TSRA)... 


More Posts From Legal

University Tech Transfer

Pitt, UPMC reach commercialization agreement

  PITTSBURGH, Feb. 20, 2015 – The University of Pittsburgh and UPMC have... 


Cellectis and Ohio State University Enter Into Licensing Agreement

  Paris, January 13, 2015 – Cellectis SA (Alternext: ALCLS.PA) announces... 


More Posts From University Tech Transfer